Trial Profile
Clinical Trials Insight: 700056402
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Rintatolimod (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 24 May 2010 New trial record
- 20 May 2010 Hemispherx plans to initiate this trial in during the 2011 flu season in China, according to a company media release.